AI assistant
Dare Bioscience, Inc. — Director's Dealing 2020
Mar 9, 2020
34825_dirs_2020-03-09_0eb7c73a-0638-4567-9730-f8a186530767.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Dare Bioscience, Inc. (DARE)
CIK: 0001401914
Period of Report: 2020-03-06
Reporting Person: Fair John A (Chief Strategy Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $1.01 | 2028-09-07 | Common stock (150000.0) | Direct | |
| Employee Stock Option (right to buy) | $0.76 | 2029-01-29 | Common stock (75000.0) | Direct |
Footnotes
F1: This stock option was granted to the reporting person on September 7, 2018 and vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.
F2: This stock option was granted to the reporting person on January 29, 2019 and vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.